The present technology is generally related to denervation of lung tissue for the treatment of chronic obstructive pulmonary disease (COPD).
COPD is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus production and wheezing. People with COPD are at increased risk of developing heart disease, lung cancer, and other diseases. Targeted lung denervation (TLD) is a surgical procedure in which a catheter is advanced through a bronchoscope to a target area within a target bronchus to denervate the target area. However, use of a bronchoscope to deliver the catheter limits the size of the catheter and constrains potential functionality of the catheter. For example, typical bronchoscopes are longer than necessary to reach the primary bronchus. As a result, a longer catheter may be needed, which reduces efficacy of therapeutic deliveries from the catheter.
The techniques of this disclosure generally relate to denervation of lung tissue for the treatment of chronic obstructive pulmonary disease.
In one aspect, the present disclosure provides a medical system for targeted lung denervation which includes an elongate shaft that has a first lumen having a first length and is sized and configured to be advanced through a trachea of a mammal, and a second lumen having a second length longer than the first length and is sized and configured to be advanced into a target bronchus of the mammal. The second lumen further includes a first expandable member at its distal end. A treatment device that has treatment element is included. The treatment device is sized and configured to be advanced through the second lumen and to denervate the target bronchus.
In another aspect of this embodiment, the treatment element includes a second expandable member configured to exchange ablative energy with the target bronchus.
In another aspect of this embodiment, the treatment element includes a second expandable member and a microwave radiator disposed within the second expandable member.
In another aspect of this embodiment, the treatment element is disposed between a pair of baluns disposed on the energy delivery device, and wherein the microwave radiator is configured to create toroidal shaped lesions within the target bronchus.
In another aspect of this embodiment, wherein, when inflated, the first expandable member is configured to provide anatomical centering of the second expandable member within the target bronchus.
In another aspect of this embodiment, the system further includes a bronchoscope sized and configured to be advanced through the elongate shaft.
In another aspect of this embodiment, the treatment element includes a plurality of electrodes configured to deliver radiofrequency energy to ablate the target bronchus.
In another aspect of this embodiment, a plurality of electrodes on the first expandable member or on the treatment device configured to determine if the target bronchus has been denervated.
In another aspect of this embodiment, the treatment device includes at least one sensor on its exterior surface, the sensor being configured to at least one from the group consisting of detect a presence of blood, measure tissue impedance, measure tissue temperature, measure tissue optical absorption or optical reflection.
In one aspect, a medical system for targeted lung denervation includes an elongate shaft having a first lumen having a first length and sized and configured to be advanced through a trachea of a mammal, and a second lumen having a second length longer than the first length and sized and configured to be advanced into a target bronchus of the mammal. The first lumen includes a cuff sized and configured to be inflated around both the first and second lumens and to create seal within the trachea when inflated. The second lumen further includes a first expandable member at its distal end. A treatment device that has a treatment element at its distal end is included. The treatment device is sized and configured to be advanced through the second lumen and to denervate the target bronchus.
In another aspect of this embodiment, the treatment element includes a second expandable member configured to exchange ablative energy with the target bronchus.
In another aspect of this embodiment, the treatment element includes a second expandable member and a microwave radiator disposed within the second expandable member.
In another aspect of this embodiment, the treatment element is disposed between a pair of baluns disposed on the treatment device, and wherein the microwave radiator is configured to create toroidal shaped lesions within the target bronchus.
In another aspect of this embodiment, wherein, when inflated, the first expandable member is configured to provide anatomical centering of the second expandable member within the target bronchus.
In another aspect of this embodiment, the system further includes a bronchoscope sized and configured to be advanced through the elongate shaft.
In another aspect of this embodiment, the treatment element includes a plurality of electrodes configured to deliver radiofrequency energy to ablate the target bronchus.
In another aspect of this embodiment, the treatment element further includes a plurality of electrodes on the first expandable member or on the treatment device configured to determine if the target bronchus has been denervated.
In another aspect of this embodiment, the system provides a means of applying stimulation to the bronchial nerves to allow for endpoint detection of nerve function. Stimulation at for example, 50 Hz applied to the nerves from electrodes in the bronchus may elicit a response which constricts the airways such that the pressure-air flow relationship is altered. Post-treatment, such an evaluation would provide an indication of procedural success. Such a system would provide means to monitor the airflow and air pressure during such testing
In one aspect, a medical system for targeted lung denervation includes an elongate shaft that has a first lumen having a first length and is sized and configured to be advanced through a trachea of a mammal, and a second lumen that has a second length longer than the first length and is sized and configured to be advanced into a target bronchus of the mammal. The first lumen includes a cuff at its distal end sized and configured to be inflated around both the first and second lumens and to create seal within the trachea when inflated. The second lumen further includes a first expandable member at its distal end. A treatment device having a treatment element at its distal end is included. The treatment device is sized and configured to be advanced through the second lumen and to denervate the target bronchus.
In one aspect, a method for targeted lung denervation includes advancing an elongate shaft through a trachea of a mammal and into a target bronchus, the elongate shaft includes a first lumen that has a first length and a second lumen that has a second length longer than the first length. The elongate shaft includes an inflatable cuff sized and configured to be inflated around both the first and second lumens and to create a seal within the trachea when inflated, and a first expandable member. The inflatable cuff is inflated to occlude the trachea. The first expandable member is inflated to contact a wall of the target bronchus. A treatment device that has a treatment element is advanced through the second lumen and into or through the first expandable member. The treatment element is configured to exchange thermal energy with the target bronchus. Thermal energy is exchanged with the target bronchus to denervate the target bronchus.
In another aspect of this embodiment, when inflated, the first expandable member is configured to provide anatomical centering of the treatment device within the target bronchus.
The details of one or more aspects of the disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the techniques described in this disclosure will be apparent from the description and drawings, and from the claims.
A more complete understanding of the present invention, and the attendant advantages and features thereof, will be more readily understood by reference to the following detailed description when considered in conjunction with the accompanying drawings wherein:
It should be understood that various aspects disclosed herein may be combined in different combinations than the combinations specifically presented in the description and accompanying drawings. It should also be understood that, depending on the example, certain acts or events of any of the processes or methods described herein may be performed in a different sequence, may be added, merged, or left out altogether (e.g., all described acts or events may not be necessary to carry out the techniques). In addition, while certain aspects of this disclosure are described as being performed by a single module or unit for purposes of clarity, it should be understood that the techniques of this disclosure may be performed by a combination of units or modules associated with, for example, a medical device.
In one or more examples, the described techniques may be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions may be stored as one or more instructions or code on a computer-readable medium and executed by a hardware-based processing unit. Computer-readable media may include non-transitory computer-readable media, which corresponds to a tangible medium such as data storage media (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that can be used to store desired program code in the form of instructions or data structures and that can be accessed by a computer).
Instructions may be executed by one or more processors, such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPGAs), or other equivalent integrated or discrete logic circuitry. Accordingly, the term “processor” as used herein may refer to any of the foregoing structure or any other physical structure suitable for implementation of the described techniques. Also, the techniques could be fully implemented in one or more circuits or logic elements.
Referring now to the drawings in which like reference designators refer to like elements, there is shown in
A treatment device 22 having a treatment element 24 may be sized and configured to be advanced through the second lumen 16 and is configured to denervate the target bronchus. For example, the treatment element 24 may be configured to denervate the target bronchus with one or more of the following modalities: cryogenic denervation, radiofrequency denervation, or microwave denervation, as discussed in more detail below. For example, as shown in
In
Referring now to
Referring now to
In yet another configuration, as shown in
As described herein, it is to be understood that the configurations of the medical device shown in
Referring now to
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described herein above. In addition, unless mention was made above to the contrary, it should be noted that all of the accompanying drawings are not to scale. A variety of modifications and variations are possible in light of the above teachings without departing from the scope and spirit of the invention, which is limited only by the following claims.
The present application is related to and claims benefit under 35 U.S.C. § 119(e) from U.S. Provisional Patent Application Ser. No. 63/326,981, filed 4 Apr. 2022, entitled “COPD TARGETED LUNG DENERVATION (TLD)”, the entire contents of which being incorporated herein by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CA2023/050428 | 3/30/2023 | WO |
Number | Date | Country | |
---|---|---|---|
63326981 | Apr 2022 | US |